T1	Participants 830 958	Sixty patients aged 18 years or older with unresectable upper abdominal cancers were randomized into two groups to receive USCPN
T2	Participants 1131 1236	Subjects were assessed for the pain relief using Numerical rating scale (NRS) to assess their pain relief
